G&S Capital »

ResMed shares owned by G&S Capital

Quarter-by-quarter ownership of ResMed (RMD) shares owned by G&S Capital from 13F filings

Historical chart of G&S Capital investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by G&S Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by G&S Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $690k 2.5k 273.73
2025-06-30 $653k 2.5k 258.00
2025-03-31 $577k 2.6k 223.85

More positions owned by G&S Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Series Trust Portfoli S&p1500 (SPTM)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Scp Etf (IJR)
International Business Machines (IBM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Chevron Corporation (CVX)
Abbvie (ABBV)
Spdr Series Trust Portfolio S&p400 (SPMD)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Goldman Sachs Etf Tr Acces Treasury (GBIL)

View all positions for G&S Capital

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
Charles Schwab Investment Management
Legal & General Group
Ubs Global Asset Management Americas
UBS Group
FMR
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding ResMed